Genesis Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Hold
3,349
– – 0.26% 43
2026
Q1
$403K Hold
3,349
– – 0.27% 39
2025
Q4
$353K Hold
3,349
– – 0.24% 43
2025
Q3
$281K Hold
3,349
– – 0.2% 48
2025
Q2
$265K Sell
3,349
-348
-9% -$27.7K 0.2% 50
2025
Q1
$332K Hold
3,697
– – 0.27% 40
2024
Q4
$368K Buy
+3,697
New +$381K 0.32% 38
2015
Q2
$333K Buy
6,137
+58
+1% +$3.25K 0.27% 35
2015
Q1
$330K Buy
6,079
+314
+5% +$17.8K 0.27% 38
2014
Q4
$322K Buy
+5,765
New +$321K 0.26% 41

Other funds holding MRK

Genesis Wealth Advisors's MRK Position: Q2 2026 in Review

Genesis Wealth Advisors held its Merck (MRK) position steady in Q2 2026 at 3,349 shares worth $430K. The position accounts for 0.26% of the portfolio, ranked #43.

Genesis Wealth Advisors first reported a position in MRK in Q4 2014 and has held it in 10 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Genesis Wealth Advisors held 3,349 shares of Merck worth $430K as of Q2 2026.
  • Genesis Wealth Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.26% of Genesis Wealth Advisors's portfolio in Q2 2026, its #43 holding.
  • Genesis Wealth Advisors first reported a position in Merck in Q4 2014 and has held it in 10 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Genesis Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.